1Friedman SL. Seminars in medicineof the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanismsand treatment strategies. N Engl J Med, 1993, 328: 1828~1835.
2Milani S, Herbst H, Schuppan D, Hahn EG, Stein H. In situ hybridization forprocollagen types Ⅰ,Ⅱ and Ⅳ mRNA in normal and fibrotic rat liver:evidence forpredominant expression in nonparenchymal liver cells. Hepatology, 1989, 10: 84~92.
3Maher JJ, McGuire RF. Extracellular matrix gene expression increases preferentiallyin rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J ClinInvest, 1990, 86:1641~1648.
4Jarnagin WR, Rockey DC, Koteliansky VE, Wang SS, Bissell DM. Expression of variantfibronectins in wound healing: cellular source and biological activity of the EIIIAsegment in rat hepatic fibrogenesis. J Cell Biol, 1994, 127 (6 Pt 2): 2037~2048.
5Geerts A, Vrijsen R, Schelliack P, Wisse E. Retinol affects the phenotype andprotein synthesis of fat storing cell derived myofibroblasts in vitro. In:Wisse E, KnookDL, Decker K, eds. Cells of the hepatic sinusoids. Leiden, The Netherlands: The KupfferCell Foundation, 1989. vol 2: 20~24.
6Mak KM, Leo MA, Lieber CS. Alcoholic liver injury in baboons: transformation oflipocytes to transitional cells. Gastroenterology, 1984, 87:188~200.
7Friedman SL. Closing in on the signals of hepatic fibrosis. Gastroenterology, 1997,112: 1406~1409.
8Pinzani M, Milani S, Grappone C, Weber FL Jr,Gentilini P, Abboud HE. Expression ofplateletderived growth factor in a model of acute liver injury. Hepatology, 1994, 19: 701~707.
9Wong L, Yamasaki G, Johnson RJ, Friedman SL.Induction of beta-platelet-derivedgrowth factor receptor in rat hepatic lipocytes during cellular activation in vivo and inculture. J Clin Invest,1994, 94: 1563~1569.
10Marra F, Gentilini A, Pinzani M, Choudhury GG,Parola M, Herbst H, Dianzani MU,Laffi G,Abboud HE, Gentilini P. Phosphatidylinositol 3-kinase is required forplatelet-derived growth factor's actions on hepatic stellate cells. Gastroenterology,1997, 112: 1297~1306.
同被引文献40
1韩德五 马学惠 等.肝硬化动物模型的研究[J].山西医药杂志,1979,(1):1-1.
2Schrier R W,Arroyo V,Bernardi M,et al. Peripheral arterial vasodilation hypothesis:a proposai for the initation of renal sodium and weter retention in cirrhosis. Hepatology,1988,8:1151.
3POVERO D, BUSLETYA C, NOVO E,et al. Liver Fibrosis: a Dy- namic and Potentially Reversible Process [ J ]. Histol Histopathol, 2010, 25(8) : 1075-91.
4SHIM J Y, KIM M H, KIM H D, et al. Protective Action of the Im- munomodulator Ginsan against Carbon Tetrachloride-Induced liver In- jury via Control of Oxidative Stress and the Inflammatory Response [ J]. Toxicology and Applied Pharmacology, 2010, 242 ( 3 ) : 318- 325.
5WASMUTH H E, TACKE F, TRAUTWEIN C. Chemokines in Liver Inflammation and Fibrosis F ,2010 [ C ]. Thieme Medical Publishers.
6DANSETI'E P, BONIERBALE E, MINOLETYI C, et al. Drug-in- duced Immunotoxicity [ J ]. European Journal of Drug Metabolism and Pharmacokinetics, 1998, 23(4) : 443-445.
7MANNS M P, VOGEL A. Autoimmune Hepatitis from Mechanisms to Therapy [J]. Hepatology, 2006, 43(1): 132-134.
8RUSSO F P, ALISON M R, BIGGER B W, et al. The Bone Marrow Functionally Contributes to Liver Fibrosis [ J ]. Gastroenterology, 2006, 130(6): 18-21.
9VIG P, RUSSO F P, EDWARDS R J,et al. The Sources of Paren- chymal Regeneration after Chronic Hepatocellular Liver Injury in Mice [J]. Hepatology, 2006, 43(2) : 316-318.
10ZAJICEK G, OREN R, WEINREB JR M. The Streaming Liver [J]. Liver, 1985, 5(6) : 293-300.